Of interest, maternal serum visfatin has been shown to regulate oxidative stress and has been identified as a novel biomarker in predicting metabolic complications in obesity during pregnancy [60,61]. Here, NAMPT is linked to obesity due to melanocortin 4 receptor deficiency.